Clinical Services

Active ingredient prescribing comes into effect

04 February, 2021 by Matthew Grant, Monash University

Doctors must now prescribe drugs using their chemical name, not brand names. That's good news for patients.


ANPC develops new COVID-19-detecting technology

03 February, 2021

A patent has been filed for advanced magnetic resonance technology that can detect the pathological signature of COVID-19 without relying on direct detection of the SARS-CoV-2 virus.


Blood cancer burden on the rise

03 February, 2021

Blood cancers are now the second most diagnosed cancers in Australia and the second most common cause of cancer-related deaths, according to the Leukaemia Foundation.


Novavax vaccine demonstrates 89.3% efficacy

03 February, 2021

Novavax has announced that its protein-based COVID-19 vaccine candidate has demonstrated a vaccine efficacy of 89.3% in a Phase 3 clinical trial conducted in the UK.


COVID-19 may reduce male fertility

01 February, 2021

A German study indicates that COVID-19 infection can cause increased sperm cell death, inflammation and oxidative stress, resulting in lower sperm quality and potentially reducing fertility.


Monash innovation reduces risk of COVID in healthcare workers

29 January, 2021

A Monash University study reveals that a simple ventilated headboard hood can stop SARS-CoV-2 from spreading between patients and healthcare workers on hospital wards.


Study predicts global cancer surgery surge

27 January, 2021

A modelling study led by UNSW Sydney predicts that global demand for cancer surgery will rise by 52% within two decades, with low-income countries bearing the greatest burden.


Hospital pharmacists prepare for vaccine rollout

27 January, 2021

With COVID-19 vaccinations set to roll out in less than one month, Australia's hospital pharmacists are preparing for their central role in the administration process.


Immunotherapy trial holds hope for children needing stem cell transplants

26 January, 2021

A new immunotherapy treatment will be studied in clinical trials, with the aim of preventing dangerous side effects for children who have to undergo stem cell transplants.


How soon will we reach herd immunity for COVID-19?

25 January, 2021 by Amy Sarcevic

Achieving herd immunity for COVID-19 may be a challenge through current vaccination programs, research from the Imperial College London has found.


TGA approves Pfizer/BioNTech vaccine

25 January, 2021

The Australian Therapeutic Goods Administration (TGA) has provisionally approved the Pfizer/BioNTech COVID-19 mRNA vaccine, COMIRNATY.


Predicting risk of spinal fracture using bioengineering

22 January, 2021 by Assistant Professor Dennis E Anderson, Brett Allaire, Dr Hossein Mokhtarzadeh and Professor Mary L Bouxsein

Researchers have developed biomechanical models that use mathematical- and physics-based representations of human movement to predict spinal loading.


UniSA test accurately predicts mood disorders

21 January, 2021

Based on levels of a specific protein found in the brain, the test is reported to be the first of its kind in the world.


REDFEB highlights how to recognise and handle a heart attack

21 January, 2021

Heart Research Australia is encouraging Australians to wear red and donate during February, to raise awareness for heart disease and funds for life-saving research.


New mammogram measures for assessing breast cancer risk

20 January, 2021

An international team of researchers, led by The University of Melbourne, has found two new mammogram-based measures for breast cancer risk.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd